NCT03570229

Brief Summary

Osteoradionecrosis, dermal soft tissue necrosis, radiation cystitis, proctitis and sexual dysfunctions are well-known late-effects after radiation for cancer in the pelvic area, negatively affecting the survivors' quality of life (QOL) and psychosocial wellbeing. Increasing evidence and clinical practice support the use of hyperbaric oxygen treatment (HBOT) as an effective treatment in a variety of radiation injuries, but this is still a field with limited research and knowledge. Especially, there is a knowledge gap on how late radiation tissue injury (LRTI) influences cancer survivors' QOL and psychosocial health in a longitudinal perspective (before, along and after HBOT), as well as the patients' knowledge, expectation and experience from this treatment. This study aims to improve knowledge on these issues.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
137

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Aug 2018

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 2, 2018

Completed
2 months until next milestone

First Posted

Study publicly available on registry

June 26, 2018

Completed
2 months until next milestone

Study Start

First participant enrolled

August 31, 2018

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2022

Completed
Last Updated

December 14, 2023

Status Verified

December 1, 2023

Enrollment Period

4.3 years

First QC Date

May 2, 2018

Last Update Submit

December 7, 2023

Conditions

Keywords

Quality of life (QOL)Hyperbaric oxygen treatment (HBOT)Late radiation tissue injury (LRTI)LongitudinalMixed methodsPatient experiences

Outcome Measures

Primary Outcomes (1)

  • Change in Quality of life after HBO-therapy

    Self reported quality of life scale, European Organization for Research and Treatment of Cancer (EORTC QLQ C30) scale, 30 questions, 4-point Likert scale 0-3 for 28 items, 0-6 for two items, total score 0-100 (100=highest level of functioning/ best score)

    Change from baseline (T1) to 30 weeks (T7, 6 months after end of HBO-therapy)

Secondary Outcomes (4)

  • Long-term change in Quality of life

    Change from baseline (T1) to 58 weeks (T8, 1 year after end of HBO-therapy)

  • Change in Late radiation tissue injury symptoms after HBO-therapy

    Change from baseline (T1) to 30 weeks (T7, 6 months after end of HBO-therapy)

  • Time to improvement in Late radiation tissue injury symptoms

    Time from baseline (T1) to significant improvement (at least 0,5 SD) up to 30 weeks (T7) after end of HBO-therapy

  • Satisfaction With Care

    T3 (after 6 weeks)

Interventions

Participants in this study will receive hyperbaric oxygen treatment (HBOT) but the investigators do not assign this specific intervention to the study participants. Thus, the patients in this study will receive HBOT as part of routine medical care. Consequently, we regard this as an observational study because the patients will get HBOT independently of the study and they are NOT assigned prospectively to HBOT according to a protocol to evaluate the effects. HBOT for pelvic radiation injury typically involves a treatment pressure of 2.4 ATA (Atmospheres Absolute) breathing oxygen for 90 minutes. The treatment is delivered as series treatment, usually daily treatment up to 30 dives.

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

This study will recruit participants from all patients with pelvic radiation injury assigned to oxygen treatment (HBOT) at Section for Hyperbaric Medicine (SHM) at Haukeland University Hospital in Bergen, being the Norwegian National Center for planned HBOT.

You may qualify if:

  • pelvic radiation injury after intended curative radiation therapy for pelvic cancer (prostate, gynecological, and urological and bowel cancers),
  • ≥ 6 months from finished radiation therapy
  • referred to the unit for hyperbaric oxgen treatment (HBOT)
  • aged ≥ 18 years.

You may not qualify if:

  • severe physical and/or mental co-morbidity representing a contraindication for HBOT
  • insufficient cognitive or language skills to answer study questionnaires and perform interviews.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Bergen/Haukeland University Hospital

Bergen, Hordaland, 5013, Norway

Location

Related Publications (33)

  • Niezgoda JA, Serena TE, Carter MJ. Outcomes of Radiation Injuries Using Hyperbaric Oxygen Therapy: An Observational Cohort Study. Adv Skin Wound Care. 2016 Jan;29(1):12-19. doi: 10.1097/01.ASW.0000473679.29537.c0.

    PMID: 26650092BACKGROUND
  • Viswanathan AN, Lee LJ, Eswara JR, Horowitz NS, Konstantinopoulos PA, Mirabeau-Beale KL, Rose BS, von Keudell AG, Wo JY. Complications of pelvic radiation in patients treated for gynecologic malignancies. Cancer. 2014 Dec 15;120(24):3870-83. doi: 10.1002/cncr.28849. Epub 2014 Jul 23.

    PMID: 25056522BACKGROUND
  • Do NL, Nagle D, Poylin VY. Radiation proctitis: current strategies in management. Gastroenterol Res Pract. 2011;2011:917941. doi: 10.1155/2011/917941. Epub 2011 Nov 17.

    PMID: 22144997BACKGROUND
  • Plafki C, Carl UM, Glag M, Hartmann KA. The treatment of late radiation effects with hyperbaric oxygenation (HBO). Strahlenther Onkol. 1998 Nov;174 Suppl 3:66-8.

    PMID: 9830461BACKGROUND
  • Gorenstein S, Katz A, Regan K, Hangan D. A retrospective case series looking at the effectiveness of hyperbaric oxygen in treating radiation cystitis. Journal of Clinical Oncology. 2015;33(7_suppl):127-127.

    BACKGROUND
  • Cancer Registry of Norway. Cancer in Norway 2015 - Cancer incidence, mortality, survival and prevalence in Norway. Oslo: Cancer Registry of Norway; 2016.

    BACKGROUND
  • Weir G. Hyperbaric oxygen therapy for complications of radiotherapy. Wound Healing South Africa. 2009;2(2):60-62.

    BACKGROUND
  • Jaeger K, Juttner B, Franko W. [Hyperbaric oxygen therapy--options and limitations]. Anasthesiol Intensivmed Notfallmed Schmerzther. 2002 Jan;37(1):38-42. doi: 10.1055/s-2002-20080. No abstract available. German.

    PMID: 11845381BACKGROUND
  • Macdonald HM. Hyperbaric oxygenation in the patient with malignancy: friend or foe? Diving and Hyperbaric Medicine. 2007;37(3):133-138.

    BACKGROUND
  • Camporesi EM. Side effects of hyperbaric oxygen therapy. Undersea Hyperb Med. 2014 May-Jun;41(3):253-7.

    PMID: 24984321BACKGROUND
  • Ennis RD. Hyperbaric oxygen for the treatment of radiation cystitis and proctitis. Curr Urol Rep. 2002 Jun;3(3):229-31. doi: 10.1007/s11934-002-0069-5.

    PMID: 12084193BACKGROUND
  • Spiegelberg L, Djasim UM, van Neck HW, Wolvius EB, van der Wal KG. Hyperbaric oxygen therapy in the management of radiation-induced injury in the head and neck region: a review of the literature. J Oral Maxillofac Surg. 2010 Aug;68(8):1732-9. doi: 10.1016/j.joms.2010.02.040. Epub 2010 May 20.

    PMID: 20493616BACKGROUND
  • Bennett MH, Feldmeier J, Hampson NB, Smee R, Milross C. Hyperbaric oxygen therapy for late radiation tissue injury. Cochrane Database Syst Rev. 2016 Apr 28;4(4):CD005005. doi: 10.1002/14651858.CD005005.pub4.

    PMID: 27123955BACKGROUND
  • Safra T, Gutman G, Fishlev G, Soyfer V, Gall N, Lessing JB, Almog R, Matcievsky D, Grisaru D. Improved quality of life with hyperbaric oxygen therapy in patients with persistent pelvic radiation-induced toxicity. Clin Oncol (R Coll Radiol). 2008 May;20(4):284-7. doi: 10.1016/j.clon.2007.12.005. Epub 2008 Jan 28.

    PMID: 18222656BACKGROUND
  • Oscarsson N, Arnell P, Lodding P, Ricksten SE, Seeman-Lodding H. Hyperbaric oxygen treatment in radiation-induced cystitis and proctitis: a prospective cohort study on patient-perceived quality of recovery. Int J Radiat Oncol Biol Phys. 2013 Nov 15;87(4):670-5. doi: 10.1016/j.ijrobp.2013.07.039. Epub 2013 Sep 11.

    PMID: 24035333BACKGROUND
  • van Ophoven A, Rossbach G, Pajonk F, Hertle L. Safety and efficacy of hyperbaric oxygen therapy for the treatment of interstitial cystitis: a randomized, sham controlled, double-blind trial. J Urol. 2006 Oct;176(4 Pt 1):1442-6. doi: 10.1016/j.juro.2006.06.065.

    PMID: 16952654BACKGROUND
  • Chong V, Rice M. The effectiveness of hyperbaric oxygen therapy (HBOT) in radiation-induced haemorrhagic cystitis. N Z Med J. 2016 Dec 2;129(1446):79-83.

    PMID: 27906922BACKGROUND
  • Ferreira C, Reis F, Correia T, et al. Hyperbaric oxygen for long-term complications of radiation cystitis. Journal of Radiotherapy in Practice. 2014;14(1):18-26.

    BACKGROUND
  • Craighead P, Shea-Budgell MA, Nation J, Esmail R, Evans AW, Parliament M, Oliver TK, Hagen NA. Hyperbaric oxygen therapy for late radiation tissue injury in gynecologic malignancies. Curr Oncol. 2011 Oct;18(5):220-7. doi: 10.3747/co.v18i5.767.

    PMID: 21980249BACKGROUND
  • Glover M, Smerdon GR, Andreyev HJ, Benton BE, Bothma P, Firth O, Gothard L, Harrison J, Ignatescu M, Laden G, Martin S, Maynard L, McCann D, Penny CEL, Phillips S, Sharp G, Yarnold J. Hyperbaric oxygen for patients with chronic bowel dysfunction after pelvic radiotherapy (HOT2): a randomised, double-blind, sham-controlled phase 3 trial. Lancet Oncol. 2016 Feb;17(2):224-233. doi: 10.1016/S1470-2045(15)00461-1. Epub 2015 Dec 17.

    PMID: 26703894BACKGROUND
  • Carr JA, Higginson IJ, Robinson PG. Quality of life. London: BMJ Books; 2003.

    BACKGROUND
  • Crosby RD, Kolotkin RL, Williams GR. Defining clinically meaningful change in health-related quality of life. J Clin Epidemiol. 2003 May;56(5):395-407. doi: 10.1016/s0895-4356(03)00044-1.

    PMID: 12812812BACKGROUND
  • Londahl M, Landin-Olsson M, Katzman P. Hyperbaric oxygen therapy improves health-related quality of life in patients with diabetes and chronic foot ulcer. Diabet Med. 2011 Feb;28(2):186-90. doi: 10.1111/j.1464-5491.2010.03185.x.

    PMID: 21219427BACKGROUND
  • Li G, Hopkins RB, Levine MAH, Jin X, Bowen JM, Thabane L, Goeree R, Fedorko L, O'Reilly DJ. Relationship between hyperbaric oxygen therapy and quality of life in participants with chronic diabetic foot ulcers: data from a randomized controlled trial. Acta Diabetol. 2017 Sep;54(9):823-831. doi: 10.1007/s00592-017-1012-z. Epub 2017 Jun 12.

    PMID: 28603808BACKGROUND
  • Harding SA, Hodder SC, Courtney DJ, Bryson PJ. Impact of perioperative hyperbaric oxygen therapy on the quality of life of maxillofacial patients who undergo surgery in irradiated fields. Int J Oral Maxillofac Surg. 2008 Jul;37(7):617-24. doi: 10.1016/j.ijom.2008.04.004. Epub 2008 May 23.

    PMID: 18501562BACKGROUND
  • Clarke RE, Tenorio LM, Hussey JR, Toklu AS, Cone DL, Hinojosa JG, Desai SP, Dominguez Parra L, Rodrigues SD, Long RJ, Walker MB. Hyperbaric oxygen treatment of chronic refractory radiation proctitis: a randomized and controlled double-blind crossover trial with long-term follow-up. Int J Radiat Oncol Biol Phys. 2008 Sep 1;72(1):134-143. doi: 10.1016/j.ijrobp.2007.12.048. Epub 2008 Mar 14.

    PMID: 18342453BACKGROUND
  • Lauvrak V, Fronsdal KB, Ormstad SS, Vaagbo G, Fure B. Effectiveness of Hyperbaric Oxygen Therapy in Patients with Late Radiation Tissue Injury or Diabetic Foot Ulcer [Internet]. Oslo, Norway: Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH); 2015 Mar. Report from Norwegian Knowledge Centre for the Health Services (NOKC) No. 4-2015. Available from http://www.ncbi.nlm.nih.gov/books/NBK390572/

    PMID: 28510406BACKGROUND
  • Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M; Medical Research Council Guidance. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ. 2008 Sep 29;337:a1655. doi: 10.1136/bmj.a1655.

    PMID: 18824488BACKGROUND
  • Creswell JW, Clark VL. Designing and conducting mixed method research. London: SAGE Publications, Inc.; 2011.

    BACKGROUND
  • Velure GK, Muller B, Hauken MA. Symptom burden, psychological distress, and health-related quality of life in cancer survivors with pelvic late radiation tissue injuries. Support Care Cancer. 2022 Mar;30(3):2477-2486. doi: 10.1007/s00520-021-06684-x. Epub 2021 Nov 15.

  • Hauken MA, Velure GK, Muller B, Sekse RJT. Sexual Health and Quality of Life in Cancer Survivors With Pelvic Radiation Injuries. Cancer Nurs. 2024 Sep-Oct 01;47(5):E298-E307. doi: 10.1097/NCC.0000000000001259. Epub 2023 Jul 14.

  • Velure GK, Muller B, Hauken MA. Symptom burden and health-related quality of life six months after hyperbaric oxygen therapy in cancer survivors with pelvic radiation injuries. Support Care Cancer. 2022 Jul;30(7):5703-5711. doi: 10.1007/s00520-022-06994-8. Epub 2022 Mar 23.

  • Velure GK, Müller B, Aa. Hauken M. Experiences of patients with pelvic radiation injuries after cancer treatment undergoing hyperbaric oxygen therapy: A phenomenological-hermeneutical study. Nordic Journal of Nursing Research. 2021;41(3):131-9.

    RESULT

MeSH Terms

Conditions

Neoplasms

Study Officials

  • May Aa Hauken, Professor

    University of Bergen

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prinsipal Investigator

Study Record Dates

First Submitted

May 2, 2018

First Posted

June 26, 2018

Study Start

August 31, 2018

Primary Completion

December 31, 2022

Study Completion

December 31, 2022

Last Updated

December 14, 2023

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will share

We plan to make IPD available to other researchers on NSD (Norwegian Scientific Data).

Shared Documents
STUDY PROTOCOL
Time Frame
After the study has finished, earliest in December 2022
Access Criteria
On request

Locations